Provided by Tiger Trade Technology Pte. Ltd.

Travere Therapeutics, Inc.

65.71
+1.251.94%
Volume:1.62M
Turnover:106.77M
Market Cap:6.19B
PE:-137.92
High:66.38
Open:64.78
Low:64.50
Close:64.46
52wk High:66.38
52wk Low:17.05
Shares:94.26M
Float Shares:92.77M
Volume Ratio:1.30
T/O Rate:1.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4764
EPS(LYR):-0.2864
ROE:-236.35%
ROA:-3.73%
PB:252.59
PE(LYR):-229.47

Loading ...

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 05

Stock Track | Travere Therapeutics Soars 7.18% as Q2 Results Beat Estimates on Robust FILSPARI Sales Growth

Stock Track
·
Aug 05

Travere Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Stock Track | Travere Therapeutics Soars 11.3% After-Hours on Strong FILSPARI Sales Growth and Q2 Product Revenue Beat

Stock Track
·
Aug 05

Travere Therapeutics Q2 Product Sales Rise on Filspari Demand

Reuters
·
Aug 05

Travere Q2 FY26 Net Loss Widens to $34.8 Million; Filspari Net Sales Rise 96% Year-over-Year to $141.1 Million

Reuters
·
Aug 05

Travere Therapeutics Q2 EPS USD -0.37

THOMSON REUTERS
·
Aug 05

Travere Therapeutics to Report Q2 Financial Results After US Market Close

Reuters
·
Jul 29

Travere Therapeutics (TVTX) Gets a Buy from Guggenheim

TIPRANKS
·
Jul 22

Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), McKesson (MCK) and TG Therapeutics (TGTX)

TIPRANKS
·
Jul 22

Exploring High Growth Tech Stocks In The US For July 2026

Simply Wall St.
·
Jul 20

Analysts Offer Insights on Healthcare Companies: Pediatrix Medical Group (MD) and Travere Therapeutics (TVTX)

TIPRANKS
·
Jul 13

Travere Therapeutics Grants Inducement Equity Awards for 41,600 Shares to Six New Employees

Reuters
·
Jul 11

Travere Therapeutics CAO Sandra Calvin to Retire; Controller John Torell Set to Succeed

Reuters
·
Jul 10

US FDA Approves Vera's Kidney Disease Drug

Reuters
·
Jul 08

Everest Medicines Closes Exclusive Licensing, Collaboration Deal with Travere for Us$112.5 Million Upfront

Reuters
·
Jul 07

Travere Therapeutics (TVTX) Could Be 3% Undervalued As Russell Value Exits Stir Questions

Simply Wall St.
·
Jul 06

Travere Therapeutics Shows Favorable Setup With Filspari as Growth Asset, Wedbush Says

MT Newswires Live
·
Jun 22

QURE Was Just the Beginning: 5 Biotech Catalysts I’m Watching Now

InvestorPlace
·
Jun 19

Travere Therapeutics Names Inrig Incoming Research Chief, Succeeding Rote

Dow Jones
·
Jun 17